hotspot -WSS

hotspot

author：focus 2025-10-02 18:05:54 - browse：873

A protestor wears a transgender flag at a hearing on banning gender-affirming health care legislation in Missouri. AP Photo/Charlie Riedel

The American Academy of Pediatrics reaffirmed its support for gender-affirming medical care for transgender children on Thursday, even as the treatments face a growing push for bans and restrictions from Republican lawmakers across the U.S.

The board of directors for the group, which represents 67,000 pediatricians, unanimously voted to reaffirm its 2018 position on the treatments. The board also voted to provide additional documents to support pediatricians, including clinical and technical reports, and to conduct an external review of research regarding the care.

“The additional recommendations also reflect the fact that the board is concerned about restrictions to accessing evidence-based health care for young people who need it,” Mark Del Monte, the academy’s CEO, said in a statement released by the group, calling the restrictions enacted by states “unprecedented government intrusion.”

“We therefore need to provide the best and most transparent process possible,” he said.

At least 21 states have now enacted laws restricting or banning gender-affirming medical care for transgender minors, and most of those states face lawsuits. A federal judge struck down Arkansas’ ban as unconstitutional, and federal judges have temporarily blocked bans in Alabama and Indiana.

The judge who struck down Arkansas’ ban cited the position of the groups in his ruling against the ban. Arkansas has appealed the judge’s decision.

People opposed to such treatments for children argue they are too young to make such decisions about their futures.

Every major medical group, including the academy and the American Medical Association, has opposed the bans and has said the treatments are safe if administered properly.

The academy and the AMA support allowing children to seek the medical care, but they don’t offer age-specific guidance.

Previous article： Affirmative action in medical school literally saved lives
Next article： Paxlovid rebound happens. Why and to whom are still a mystery

WSS

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

'Brian's Song' at 50 still offers lessons about cancer for today

A solution to the after

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

6 phony surgeries that take placebo to the extreme

focus

hotspot

leisure time

Wildfire smoke exposes gaps in outdoor worker protections

Feed a cold, starve a fever? Here’s what science says

Medicare proposal to cover medical devices draws a mixed reaction

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

Psychedelics group wrestles with new pharma identity

'Brian's Song' at 50 still offers lessons about cancer for today

Trump demands the U.S. pay no more for drugs than other countries … again

A new nitrogen execution bill also undermines medical licensing

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

knowledge

Paxlovid rebound happens. Why and to whom are still a mystery

Sage considers ways to reduce costs following FDA rejection

How CRISPR works, explained in two minutes

With competition flaring, obesity drug hits goal in liver disease study

Paxlovid rebound happens. Why and to whom are still a mystery

In utero gene editing: an explainer

explore

leisure time

hotspot

Wikipedia